NLRP3 and Parkinson disease: Li et al.'s study in 2018 explained miR-30e role in MPTP-treated Parkinson's disease mice caused reduction of neuroinflammation by decreasing (nod-like receptor protein 3) Nlrp3 inflammasome activity57.